<DOC>
	<DOCNO>NCT00992238</DOCNO>
	<brief_summary>The purpose study compare relative bioavailability Flavoxate Hydrochloride tablets 100mg manufactured Paddock Laboratories , Inc. , UrispasÂ® tablets 100mg SmithKline Beecham Pharmaceuticals fast condition .</brief_summary>
	<brief_title>A Relative Bioavailability Study 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Flavoxate</mesh_term>
	<criteria>Good health determine lack clinically significant abnormality health assessment perform screen Positive test result HIV Hepatitis B C History allergy sensitivity Flavoxate hydrochloride relate drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>